LGND Competitors & Alternatives
Compare Ligand Pharmaceuticals Incorporated with similar stocks in the same industry
Biotechnology
LGND
Main Stock$303.53
Tradestie Score
50
Market Cap
$3.49B
P/E Ratio
32.4
Revenue Growth
0.3%
Analyst Upside
+13.9%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 39 | Compare |
|
CYTK
Cytokinetics Inc.
|
$61.23
|
$6.68B | - | 64 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$89.27
|
$6.64B | - | 75 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$88.01
|
$6.38B | - | 59 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$19.27
|
$6.03B | - | 44 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$49.39
|
$6.02B | - | 52 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$145.04
|
$5.92B | - | 43 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$54.17
|
$5.80B | 19.3 | 57 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$311.50
|
$5.20B | 40.1 | 49 | Compare |
More LGND Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry